Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses: Double-blind, Randomized, Placebo-controlled Clinical Study

NCT04352959 is registered in ClinicalTrials.gov with Claude Bernard University as lead sponsor.

NCT NCT04352959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04352959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses: Double-blind, Randomized, Placebo-controlled Clinical Study
Lead sponsor
Claude Bernard University
Phase
Not applicable
Overall status
Completed
Start date
April 27, 2020
Completion date
December 11, 2020
Enrollment
176 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, mouthwash, saliva